CA Stock MarketDetailed Quotes
CTX Crescita Therapeutics Inc
- 0.560
- +0.020+3.70%
15min DelayMarket Closed Dec 13 16:00 ET
10.71MMarket Cap-4.00P/E (TTM)
0.560High0.560Low500Volume0.560Open0.540Pre Close280.00Turnover0.69052wk High0.00%Turnover Ratio19.12MShares0.36052wk Low-0.14EPS TTM9.41MFloat Cap2.000Historical HighLossP/E (Static)16.80MShs Float0.350Historical Low-0.1EPS LYR0.00%Amplitude--Dividend TTM0.67P/B1Lot Size--Div YieldTTM
Crescita Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M | 13.92%9.39M | 13.92%9.39M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M | -27.30%8.24M | -27.30%8.24M |
| -Cash and cash equivalents | -15.80%8.44M | -11.87%9.01M | -7.24%9.53M | 13.92%9.39M | 13.92%9.39M | -6.68%10.02M | -2.63%10.23M | -12.49%10.28M | -27.30%8.24M | -27.30%8.24M |
| Receivables | -48.77%1.27M | -39.16%2.3M | -17.47%3.51M | -55.52%2.78M | -55.52%2.78M | -33.41%2.48M | 2.72%3.78M | 20.38%4.25M | 66.51%6.24M | 66.51%6.24M |
| -Accounts receivable | -52.54%1.1M | -40.36%2.19M | -17.70%3.45M | -73.91%1.19M | -73.91%1.19M | -34.79%2.32M | 2.63%3.67M | 20.71%4.2M | 116.47%4.56M | 116.47%4.56M |
| -Taxes receivable | ---- | ---- | ---- | -79.21%21K | -79.21%21K | ---- | ---- | ---- | -30.34%101K | -30.34%101K |
| -Other receivables | 5.59%170K | 1.85%110K | 0.00%56K | -0.82%1.56M | -0.82%1.56M | -4.17%161K | 5.88%108K | 0.00%56K | 5.48%1.58M | 5.48%1.58M |
| Inventory | 4.09%6.13M | -1.07%5.27M | -7.24%5.06M | 8.48%6.13M | 8.48%6.13M | 17.99%5.89M | 7.94%5.33M | 10.07%5.45M | 28.55%5.65M | 28.55%5.65M |
| Prepaid assets | ---- | ---- | ---- | -48.60%202K | -48.60%202K | ---- | ---- | ---- | -36.82%393K | -36.82%393K |
| Other current assets | 5.95%445K | 66.91%454K | -36.17%270K | ---- | ---- | -28.93%420K | -55.56%272K | -33.91%423K | ---- | ---- |
| Total current assets | -13.44%16.29M | -13.11%17.04M | -9.97%18.37M | -9.89%18.49M | -9.89%18.49M | -6.16%18.81M | -0.63%19.61M | -2.23%20.41M | 2.11%20.52M | 2.11%20.52M |
| Non current assets | ||||||||||
| Net PPE | 21.57%2.27M | -16.99%1.66M | -21.94%1.68M | -20.02%1.85M | -20.02%1.85M | -21.02%1.86M | -20.26%2M | -17.21%2.15M | -10.40%2.31M | -10.40%2.31M |
| -Gross PPE | 21.57%2.27M | -16.99%1.66M | -21.94%1.68M | -5.03%4.46M | -5.03%4.46M | -21.02%1.86M | -20.26%2M | -17.21%2.15M | -1.22%4.69M | -1.22%4.69M |
| -Accumulated depreciation | ---- | ---- | ---- | -9.48%-2.61M | -9.48%-2.61M | ---- | ---- | ---- | -9.66%-2.39M | -9.66%-2.39M |
| Investments and advances | -3.53%355K | -2.23%351K | -0.29%349K | 4.68%358K | 4.68%358K | 19.48%368K | 16.18%359K | 7.36%350K | 1.18%342K | 1.18%342K |
| -Long term equity investment | -3.53%355K | -2.23%351K | -0.29%349K | 4.68%358K | 4.68%358K | 19.48%368K | 16.18%359K | 7.36%350K | 1.18%342K | 1.18%342K |
| Non current accounts receivable | -3.69%1.44M | -6.31%1.43M | -7.63%1.45M | -5.86%1.48M | -5.86%1.48M | 2.05%1.49M | 0.73%1.52M | -0.19%1.57M | -5.65%1.57M | -5.65%1.57M |
| Non current note receivables | 6.76%458K | 6.64%450K | 4.24%443K | 2.11%436K | 2.11%436K | -4.45%429K | -3.65%422K | -18.74%425K | -16.76%427K | -16.76%427K |
| Goodwill and other intangible assets | -14.79%1.88M | -16.30%2.03M | -32.97%1.78M | -30.46%1.99M | -30.46%1.99M | -28.33%2.21M | -26.46%2.43M | -24.82%2.65M | -23.37%2.87M | -23.37%2.87M |
| -Other intangible assets | ---- | ---- | ---- | -30.46%1.99M | -30.46%1.99M | ---- | ---- | ---- | -23.37%2.87M | -23.37%2.87M |
| Non current deferred assets | ---- | ---- | ---- | --0 | --0 | --196K | --196K | --289K | --455K | --455K |
| Total non current assets | -2.44%6.4M | -14.55%5.92M | -23.36%5.7M | -23.31%6.11M | -23.31%6.11M | -14.41%6.56M | -14.14%6.92M | -12.98%7.44M | -9.77%7.97M | -9.77%7.97M |
| Total assets | -10.59%22.68M | -13.48%22.95M | -13.55%24.07M | -13.64%24.6M | -13.64%24.6M | -8.44%25.37M | -4.55%26.53M | -5.35%27.84M | -1.52%28.48M | -1.52%28.48M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | 8.37%453K | 8.21%448K | 8.29%444K | 8.40%439K | 8.40%439K | 10.29%418K | 10.40%414K | -69.83%410K | -69.84%405K | -69.84%405K |
| -Current capital lease obligation | 8.37%453K | 8.21%448K | 8.29%444K | 8.40%439K | 8.40%439K | 10.29%418K | 10.40%414K | 10.51%410K | 10.35%405K | 10.35%405K |
| Other current liabilities | 0.00%50K | 0.00%50K | 0.00%50K | 100.00%100K | 100.00%100K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K | 0.00%50K |
| Current liabilities | 15.58%6.04M | 5.37%5.06M | -11.08%5.12M | -19.70%4.86M | -19.70%4.86M | -17.48%5.22M | -24.58%4.8M | -26.24%5.76M | -9.93%6.06M | -9.93%6.06M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -46.97%473K | -41.14%588K | -36.41%702K | -32.53%815K | -32.53%815K | -28.01%892K | -25.17%999K | -22.80%1.1M | -20.79%1.21M | -20.79%1.21M |
| -Long term capital lease obligation | -46.97%473K | -41.14%588K | -36.41%702K | -32.53%815K | -32.53%815K | -28.01%892K | -25.17%999K | -22.80%1.1M | -20.79%1.21M | -20.79%1.21M |
| Other non current liabilities | -20.57%112K | -20.74%107K | -20.93%102K | -21.14%97K | -21.14%97K | -15.57%141K | -15.63%135K | -15.69%129K | -16.33%123K | -16.33%123K |
| Total non current liabilities | -43.37%585K | -38.71%695K | -34.79%804K | -31.48%912K | -31.48%912K | -26.53%1.03M | -24.15%1.13M | -22.11%1.23M | -20.39%1.33M | -20.39%1.33M |
| Total liabilities | 5.85%6.62M | -3.05%5.76M | -15.26%5.93M | -21.82%5.78M | -21.82%5.78M | -19.12%6.26M | -24.50%5.94M | -25.55%6.99M | -12.02%7.39M | -12.02%7.39M |
| Shareholders'equity | ||||||||||
| Share capital | -4.16%53.05M | -4.81%53.6M | -4.29%53.89M | -3.49%54.34M | -3.49%54.34M | -2.23%55.35M | -1.88%56.3M | -2.53%56.3M | -3.06%56.3M | -3.06%56.3M |
| -common stock | -4.16%53.05M | -4.81%53.6M | -4.29%53.89M | -3.49%54.34M | -3.49%54.34M | -2.23%55.35M | -1.88%56.3M | -2.53%56.3M | -3.06%56.3M | -3.06%56.3M |
| Additional paid-in capital | 39.37%7.08M | 53.37%6.63M | 47.92%6.36M | 39.45%5.96M | 39.45%5.96M | 26.95%5.08M | 27.95%4.32M | 40.81%4.3M | 54.24%4.27M | 54.24%4.27M |
| Retained earnings | -6.45%-45.19M | -7.25%-44.15M | -5.72%-43.23M | -4.89%-42.6M | -4.89%-42.6M | -1.57%-42.45M | 1.95%-41.17M | 2.53%-40.89M | 2.08%-40.61M | 2.08%-40.61M |
| Gains losses not affecting retained earnings | -1.06%1.12M | -0.97%1.12M | -0.88%1.12M | -0.88%1.12M | -0.88%1.12M | -1.65%1.13M | -1.73%1.13M | -1.74%1.13M | -1.22%1.13M | -1.22%1.13M |
| Total stockholders'equity | -15.98%16.06M | -16.49%17.2M | -12.97%18.14M | -10.78%18.82M | -10.78%18.82M | -4.31%19.12M | 3.33%20.59M | 4.12%20.85M | 2.78%21.1M | 2.78%21.1M |
| Total equity | -15.98%16.06M | -16.49%17.2M | -12.97%18.14M | -10.78%18.82M | -10.78%18.82M | -4.31%19.12M | 3.33%20.59M | 4.12%20.85M | 2.78%21.1M | 2.78%21.1M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data